VINBLASTINE SULFATE INJECTION DIN 02183056
Health Canada record
| Active ingredient(s) | VINBLASTINE SULFATE 1 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01CA01 VINBLASTINE |
| Original market date | 14-Apr-1998 |
| Current status date | 31-Jul-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing VINBLASTINE SULFATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02401460 | VINBLASTINE SULPHATE INJECTION | TEVA CANADA LIMITED | Solution | VINBLASTINE SULFATE 1 MG | Marketed |
| 00015431 | VELBE 1MG/ML | ELI LILLY CANADA INC | Powder For Solution | VINBLASTINE SULFATE 10 MG | Cancelled Post Market |
| 01977784 | VINBLASTINE SULFATE INJ 1MG/ML | DAVID BULL LABORATORIES (PTY) LTD. | Liquid | VINBLASTINE SULFATE 1 MG | Cancelled Post Market |
| 02406675 | VINBLASTINE SULFATE INJECTION | SANDOZ CANADA INCORPORATED | Solution | VINBLASTINE SULFATE 1 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19663 | 2017-08-16 | New Drug Submission (NDS) | MERGER - BUYOUT |
| 8856 | 2007-06-21 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 820 | 2002-11-29 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 5290 | 1995-09-18 | New Drug Submission (NDS) |
International API supply for VINBLASTINE SULFATE
2 valid EDQM Certificates of Suitability from 2 holders. 3 active FDA Drug Master Files.
Request a quote for VINBLASTINE SULFATE INJECTION